Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abeona Therapeutics 6555 Carnegie Avenue 4thFloor Cleveland OH 44103 USA

www.abeonatherapeutics.com P: 646-813-4701

Description:

Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.

Key Statistics

Overview:

Market Capitalization, $K 206,454
Enterprise Value, $K 191,644
Shares Outstanding, K 40,963
Annual Sales, $ 3,500 K
Annual Net Income, $ -54,190 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -31,580 K
EBIT, $ -49,420 K
EBITDA, $ -46,220 K
60-Month Beta 1.59
% of Insider Shareholders 5.30%
% of Institutional Shareholders 80.56%
Float, K 38,792
% Float 94.70%
Short Volume Ratio 0.37

Growth:

1-Year Return 35.36%
3-Year Return -84.61%
5-Year Return -93.66%
5-Year Revenue Growth 16.67%
5-Year Earnings Growth 93.11%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.53 on 05/15/24
Next Earnings Date 08/13/24
Earnings Per Share ttm -2.09
EPS Growth vs. Prev Qtr 17.19%
EPS Growth vs. Prev Year 1.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 07/05/22

ABEO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -543.60%
Return-on-Assets % -78.51%
Profit Margin % -1,548.29%
Debt/Equity -2.04
Price/Sales 63.43
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.32
Interest Coverage -128.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar